In Re Hubbell Puts Inventors at a Disadvantage

The Drug Enforcement Administration and the U.S. Department of Health & Human Services just finalized their March 2023 proposed rule regarding telemedicine prescribing of buprenorphine.

This executive order builds upon EO 14028 to modernize the federal government’s cybersecurity posture while expanding on requirements imposed on third-party suppliers.